Compounds > 6-aminophenanthridine
Page last updated: 2024-09-04

6-aminophenanthridine and Oculopharyngeal Dystrophy

6-aminophenanthridine has been researched along with Oculopharyngeal Dystrophy in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbezier, N; Bidet, Y; Blondel, M; Buttstedt, A; Chartier, A; Galons, H; Schwarz, E; Simonelig, M; Voisset, C1
Blondel, M; Saupe, SJ; Voisset, C1

Reviews

1 review(s) available for 6-aminophenanthridine and Oculopharyngeal Dystrophy

ArticleYear
The various facets of the protein-folding activity of the ribosome.
    Biotechnology journal, 2011, Volume: 6, Issue:6

    Topics: Guanabenz; Molecular Chaperones; Muscular Dystrophy, Oculopharyngeal; Phenanthridines; Prion Diseases; Protein Biosynthesis; Protein Folding; Proteins; Ribosomes; RNA, Ribosomal

2011

Other Studies

1 other study(ies) available for 6-aminophenanthridine and Oculopharyngeal Dystrophy

ArticleYear
Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy.
    EMBO molecular medicine, 2011, Volume: 3, Issue:1

    Topics: Animals; Drosophila; Guanabenz; Larva; Muscular Dystrophy, Oculopharyngeal; Phenanthridines; Phenotype; Poly(A)-Binding Protein II; Prion Diseases; Protein Folding; RNA, Ribosomal

2011